| Zia Ur Rahman, MD | |
|
929 Sw Mulvane St, Topeka, KS 66606-1677 | |
| (828) 687-6282 | |
| (828) 687-6285 |
| Full Name | Zia Ur Rahman |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 23 Years |
| Location | 929 Sw Mulvane St, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386838811 | NPI | - | NPPES |
| 7100048740 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 04-41898 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Geary Community Hospital | Junction city, KS | Hospital |
| Newman Regional Health | Emporia, KS | Hospital |
| Holton Community Hospital | Holton, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
Dramatic increases in exposure to toxic chemicals in the last four decades are threatening human reproduction and health, according to the International Federation of Gynecology and Obstetrics (FIGO), the first global reproductive health organization to take a stand on human exposure to toxic chemicals.
The Foundation for Embryonic Competence is pleased to recognize Dr. Rachel S. Weinerman, a clinical assistant professor, reproductive endocrinology and infertility at University Hospitals Case Medical in Cleveland, for receiving the 2015 Scientific Program Prize Paper Award at the 71st Annual American Society for Reproductive Medicine conference in Baltimore, Maryland on October 21, 2015.
Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
Virdante Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has granted a key patent that supports the Company's "Sialic Switch" technology for improving the anti-inflammatory activity of antibody-based drugs to treat autoimmune and inflammatory disorders.
› Verified 9 days ago
| Entity Name | Cotton O'neil Clinic Revocable Trust |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
Dramatic increases in exposure to toxic chemicals in the last four decades are threatening human reproduction and health, according to the International Federation of Gynecology and Obstetrics (FIGO), the first global reproductive health organization to take a stand on human exposure to toxic chemicals.
The Foundation for Embryonic Competence is pleased to recognize Dr. Rachel S. Weinerman, a clinical assistant professor, reproductive endocrinology and infertility at University Hospitals Case Medical in Cleveland, for receiving the 2015 Scientific Program Prize Paper Award at the 71st Annual American Society for Reproductive Medicine conference in Baltimore, Maryland on October 21, 2015.
Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
Virdante Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has granted a key patent that supports the Company's "Sialic Switch" technology for improving the anti-inflammatory activity of antibody-based drugs to treat autoimmune and inflammatory disorders.
› Verified 9 days ago
| Entity Name | Stormont Vail Health Flint Hills Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952018608 PECOS PAC ID: 9032587472 Enrollment ID: O20230429000051 |
News Archive
Dramatic increases in exposure to toxic chemicals in the last four decades are threatening human reproduction and health, according to the International Federation of Gynecology and Obstetrics (FIGO), the first global reproductive health organization to take a stand on human exposure to toxic chemicals.
The Foundation for Embryonic Competence is pleased to recognize Dr. Rachel S. Weinerman, a clinical assistant professor, reproductive endocrinology and infertility at University Hospitals Case Medical in Cleveland, for receiving the 2015 Scientific Program Prize Paper Award at the 71st Annual American Society for Reproductive Medicine conference in Baltimore, Maryland on October 21, 2015.
Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
Virdante Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has granted a key patent that supports the Company's "Sialic Switch" technology for improving the anti-inflammatory activity of antibody-based drugs to treat autoimmune and inflammatory disorders.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zia Ur Rahman, MD 929 Sw Mulvane St, Topeka, KS 66606-1677 Ph: (785) 274-1007 | Zia Ur Rahman, MD 929 Sw Mulvane St, Topeka, KS 66606-1677 Ph: (828) 687-6282 |
News Archive
Dramatic increases in exposure to toxic chemicals in the last four decades are threatening human reproduction and health, according to the International Federation of Gynecology and Obstetrics (FIGO), the first global reproductive health organization to take a stand on human exposure to toxic chemicals.
The Foundation for Embryonic Competence is pleased to recognize Dr. Rachel S. Weinerman, a clinical assistant professor, reproductive endocrinology and infertility at University Hospitals Case Medical in Cleveland, for receiving the 2015 Scientific Program Prize Paper Award at the 71st Annual American Society for Reproductive Medicine conference in Baltimore, Maryland on October 21, 2015.
Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
Virdante Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has granted a key patent that supports the Company's "Sialic Switch" technology for improving the anti-inflammatory activity of antibody-based drugs to treat autoimmune and inflammatory disorders.
› Verified 9 days ago
Dr. Jerry R. Majers, D.O. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Topeka, KS 66622 Phone: 785-350-3111 | |
James Patrick Birkbeck, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 | |
Dr. Steven E Seals, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 Fax: 785-270-4202 | |
John L Joliff, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 600 Sw College Ave, Topeka, KS 66606 Phone: 784-233-9643 Fax: 785-233-6821 | |
Amarinder Pal Singh, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 Sw 7th Street, Topeka, KS 66606 Phone: 785-295-8000 Fax: 785-231-5988 | |
Dr. Craig F Gernon, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 Fax: 785-270-4177 | |
Bradley W Marples, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 901 Sw Garfield Ave, Topeka, KS 66606 Phone: 785-354-9595 |